Impact Factor 3.113 | CiteScore 3.03
More on impact ›
This section provides an Open Access publication forum with rapid turnaround, for high quality research in pulmonary diseases, utilizing an online strategy and efficient review process.
The aim is to act as a platform for translational research between scientists and clinicians. Research findings which improve our understanding in the early origin of lung diseases, amongst which, genetic and epigenetic influences related to early environmental factors should be addressed. Research on lifestyle impacting inflammatory mechanisms and premature aging of the lung should be a focus of this forum, to help in the prevention of several chronic lung diseases. Various environmental factors leading to different phenotypes of asthma all through life are of interest. The role of microbiote and dysbiose to worsen or protect from chronic, obstructive, or restrictive lung diseases, are of interest in view of the specific compartmentalization of our defenses to protect our terminal airways to ensure gas exchanges. Studies that integrate cellular, molecular, biochemical and proteomic aspects of lung injury and repair, allowing novel pharmacological approaches are welcome. Due to the abundance of novel technologies available, room will be made to integrate new functional and metabolic imaging. Potential biomarkers to diagnose or monitor lung inflammation are expected. New biological treatments or interventions in the developing area of personalized medicine should be reflected in the Respiratory Medicine section of Frontiers in Medicine.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, Emerging Sources Citation Index, CLOCKSS
PMCID: all published articles receive a PMCID
Pulmonary Medicine welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Editorial, General Commentary, Methods, Mini Review, Original Research, Perspective, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Pulmonary Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Pulmonary Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Medicine.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org